Zurich Stocks Rise; Novartis Drug Test Results Eyed -- Market Talk
August 29 2014 - 12:46PM
Dow Jones News
The SMI stocks index in Zurich adds 0.43% to 8658.97. Novartis
rises 0.43% ahead of the results presentation for an important
heart drug test at a European conference on Saturday. Fellow pharma
giant Roche climbs 0.22%, while Actelion, Europe's biggest biotech,
adds 1.35%. Julius Baer rises 2.3% after a local blog speculated
the private bank might get bought out by Credit Suisse, which adds
0.58%. UBS climbs 0.73%. Swisscom falls 0.19% even after saying
Switzerland's competition authorities had blessed its acquisition
of marketing firm PubliGroupe. (andrew.morse@wsj.com)
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
Swisscom (PK) (USOTC:SCMWY)
Historical Stock Chart
From Jun 2024 to Jul 2024
Swisscom (PK) (USOTC:SCMWY)
Historical Stock Chart
From Jul 2023 to Jul 2024